Operating Lease, Liability, Noncurrent of Surface Oncology, Inc. from 31 Mar 2019 to 30 Jun 2023
- Taxonomy & unit
- us-gaap: USD
- Description
- Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
- Summary
-
Surface Oncology, Inc. quarterly Operating Lease, Liability, Noncurrent in USD history and change rate from 31 Mar 2019 to 30 Jun 2023.
- Surface Oncology, Inc. Operating Lease, Liability, Noncurrent for the quarter ending 30 Jun 2023 was $0, a 100% decline year-over-year.
- Source SEC data
- View on sec.gov
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Change (%)
Surface Oncology, Inc. Quarterly Operating Lease, Liability, Noncurrent (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q2 2023 | $0 | -$26,019,000 | -100% | 30 Jun 2023 | 10-Q | 02 Aug 2023 | 2023 | Q2 |
| Q1 2023 | $23,939,000 | -$2,745,000 | -10% | 31 Mar 2023 | 10-Q | 04 May 2023 | 2023 | Q1 |
| Q4 2022 | $24,662,000 | -$2,247,000 | -8.4% | 31 Dec 2022 | 10-Q | 02 Aug 2023 | 2023 | Q2 |
| Q3 2022 | $25,348,000 | -$2,078,000 | -7.6% | 30 Sep 2022 | 10-Q | 02 Nov 2022 | 2022 | Q3 |
| Q2 2022 | $26,019,000 | -$1,911,000 | -6.8% | 30 Jun 2022 | 10-Q | 03 Aug 2022 | 2022 | Q2 |
| Q1 2022 | $26,684,000 | -$1,748,000 | -6.1% | 31 Mar 2022 | 10-Q | 09 May 2022 | 2022 | Q1 |
| Q4 2021 | $26,909,000 | -$2,072,000 | -7.2% | 31 Dec 2021 | 8-K | 03 Jul 2023 | ||
| Q3 2021 | $27,426,000 | -$1,938,000 | -6.6% | 30 Sep 2021 | 10-Q | 04 Nov 2021 | 2021 | Q3 |
| Q2 2021 | $27,930,000 | -$1,762,000 | -5.9% | 30 Jun 2021 | 10-Q | 05 Aug 2021 | 2021 | Q2 |
| Q1 2021 | $28,432,000 | -$1,453,000 | -4.9% | 31 Mar 2021 | 10-Q | 05 May 2021 | 2021 | Q1 |
| Q4 2020 | $28,981,000 | +$12,013,000 | +71% | 31 Dec 2020 | 10-K | 02 Mar 2022 | 2021 | FY |
| Q3 2020 | $29,364,000 | +$9,741,000 | +50% | 30 Sep 2020 | 10-Q | 10 Nov 2020 | 2020 | Q3 |
| Q2 2020 | $29,692,000 | +$9,738,000 | +49% | 30 Jun 2020 | 10-Q | 11 Aug 2020 | 2020 | Q2 |
| Q1 2020 | $29,885,000 | +$9,602,000 | +47% | 31 Mar 2020 | 10-Q | 12 May 2020 | 2020 | Q1 |
| Q4 2019 | $16,968,000 | 31 Dec 2019 | 10-K | 09 Mar 2021 | 2020 | FY | ||
| Q3 2019 | $19,623,000 | 30 Sep 2019 | 10-Q | 12 Nov 2019 | 2019 | Q3 | ||
| Q2 2019 | $19,954,000 | 30 Jun 2019 | 10-Q | 07 Aug 2019 | 2019 | Q2 | ||
| Q1 2019 | $20,283,000 | 31 Mar 2019 | 10-Q | 09 May 2019 | 2019 | Q1 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.